Cozaar (losartan) for preventing stroke

Merck will now promote Cozaar (losartan) for preventing stroke.

FDA just approved this new indication for patients with hypertension and left ventricular hypertrophy.

These patients have about twice the risk for stroke compared to patients without left ventricular hypertrophy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote